Amid a tense battle between Hillary Clinton and Bernie Sanders over competing visions for health care, a leading Wall Street analyst has put out a report saying that Clinton would be the best candidate for health care investors.
In a report titled “Healthcare: Our 2016 Outlook,”Jeffrey Loo of S&P Capital’s IQ Healthcare Equity Research writes that Clinton should be the preferred choice for the industry because she will preserve the Affordable Care Act and be unable to pass meaningful drug reform legislation:
Overall, we believe the best scenario for healthcare investors is a Democrat, presumably Hillary Clinton, winning the Presidency, as we anticipate the Republicans retaining control of Congress. In this scenario, in spite of Clinton’s numerous “threats” to rein in drug prices, allowing the re-importation of drugs, and allowing Medicare to negotiate drug prices, we believe it is highly unlikely Clinton will be able to pass these initiatives through a Republican controlled Congress. Conversely, the Republicans’ efforts to repeal Healthcare Reform, would be thwarted by a Clinton veto as we do not anticipate the Republican obtaining the 2/3 votes to override a veto.
The report makes clear that it views the gridlock created by a Clinton administration paired with a GOP Congress as the rosiest picture for the health care industry.
Clinton has frequently boasted about her record during the 1990s. “I fought really hard,”she said at a Democratic town hall earlier this month. “The insurance companies and the drug companies spent millions against me. I know what it’s like to go up against the status quo and special interests.”
But now, it appears, they’re rooting for her.
IT’S EVEN WORSE THAN WE THOUGHT.
What we’re seeing right now from Donald Trump is a full-on authoritarian takeover of the U.S. government.
This is not hyperbole.
Court orders are being ignored. MAGA loyalists have been put in charge of the military and federal law enforcement agencies. The Department of Government Efficiency has stripped Congress of its power of the purse. News outlets that challenge Trump have been banished or put under investigation.
Yet far too many are still covering Trump’s assault on democracy like politics as usual, with flattering headlines describing Trump as “unconventional,” “testing the boundaries,” and “aggressively flexing power.”
The Intercept has long covered authoritarian governments, billionaire oligarchs, and backsliding democracies around the world. We understand the challenge we face in Trump and the vital importance of press freedom in defending democracy.
We’re independent of corporate interests. Will you help us?
IT’S BEEN A DEVASTATING year for journalism — the worst in modern U.S. history.
We have a president with utter contempt for truth aggressively using the government’s full powers to dismantle the free press. Corporate news outlets have cowered, becoming accessories in Trump’s project to create a post-truth America. Right-wing billionaires have pounced, buying up media organizations and rebuilding the information environment to their liking.
In this most perilous moment for democracy, The Intercept is fighting back. But to do so effectively, we need to grow.
That’s where you come in. Will you help us expand our reporting capacity in time to hit the ground running in 2026?
We’re independent of corporate interests. Will you help us?
I’M BEN MUESSIG, The Intercept’s editor-in-chief. It’s been a devastating year for journalism — the worst in modern U.S. history.
We have a president with utter contempt for truth aggressively using the government’s full powers to dismantle the free press. Corporate news outlets have cowered, becoming accessories in Trump’s project to create a post-truth America. Right-wing billionaires have pounced, buying up media organizations and rebuilding the information environment to their liking.
In this most perilous moment for democracy, The Intercept is fighting back. But to do so effectively, we need to grow.
That’s where you come in. Will you help us expand our reporting capacity in time to hit the ground running in 2026?
We’re independent of corporate interests. Will you help us?
Latest Stories
The Intercept Briefing
“Me Too” Comes Back To Congress
Intercept staffers discuss the themes emerging this midterm election season.
Voices
Kash Patel Is Using MAGA’s Favorite Tool to Muzzle the Free Press
By suing The Atlantic for defamation, the FBI director is leveraging one of Trump’s legal tactics to tamp down free speech.
License to Kill
Trump Has Already Spent at Least $4.7 Billion Attacking Latin America
It’s not cheap to attack Venezuela and capture its president or conduct dozens of strikes on civilian boats.